Terms: = Lung cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Staging
16 results:
1. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via pi3k/Akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in lung Adenocarcinoma.
Xuan DTM; Yeh IJ; Su CY; Liu HL; Ta HDK; Anuraga G; Chiao CC; Wang CY; Yen MC
Int J Med Sci; 2023; 20(1):87-101. PubMed ID: 36619227
[TBL] [Abstract] [Full Text] [Related]
3. Highly sensitive and simultaneous detection of ctDNAs related to non-small cell lung cancer in serum using a catalytic hairpin assembly strategy in a SERS microfluidic chip.
Cao X; Mao Y; Gu Y; Ge S; Lu W; Gu Y; Li Z
J Mater Chem B; 2022 Aug; 10(32):6194-6206. PubMed ID: 35904034
[TBL] [Abstract] [Full Text] [Related]
4. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract] [Full Text] [Related]
5. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the pi3k/AKT signaling pathway.
Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X
Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the pi3k/AKT pathway.
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
[TBL] [Abstract] [Full Text] [Related]
7. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
Han K; Zhang Y
J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP lungscape Project.
Kerr KM; Dafni U; Schulze K; Thunnissen E; Bubendorf L; Hager H; Finn S; Biernat W; Vliegen L; Losa JH; Marchetti A; Cheney R; Warth A; Speel EJ; Blackhall F; Monkhorst K; Jantus Lewintre E; Tischler V; Clark C; Bertran-Alamillo J; Meldgaard P; Gately K; Wrona A; Vandenberghe P; Felip E; De Luca G; Savic S; Muley T; Smit EF; Dingemans AC; Priest L; Baas P; Camps C; Weder W; Polydoropoulou V; Geiger TR; Kammler R; Sumiyoshi T; Molina MA; Shames DS; Stahel RA; Peters S;
Ann Oncol; 2018 Jan; 29(1):200-208. PubMed ID: 29186353
[TBL] [Abstract] [Full Text] [Related]
9. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
Schneider F; Derrick V; Davison JM; Strollo D; Incharoen P; Dacic S
Mod Pathol; 2016 Jul; 29(7):735-42. PubMed ID: 27080983
[TBL] [Abstract] [Full Text] [Related]
10. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract] [Full Text] [Related]
12. Associations between clinical characteristics and oncogene expression in patients with non-small cell lung cancer.
Han Y; Yu DP; Zhou SJ; Song XY; Li YS; Xiao N; Liu ZD; Sun XJ; Zhao QY; Liu SK
Genet Mol Res; 2014 Oct; 13(4):8913-24. PubMed ID: 25366782
[TBL] [Abstract] [Full Text] [Related]
13. AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis.
Ke ZF; Mao X; Zeng C; He S; Li S; Wang LT
Med Oncol; 2013 Mar; 30(1):383. PubMed ID: 23307243
[TBL] [Abstract] [Full Text] [Related]
14. TOPK/PBK promotes cell migration via modulation of the pi3k/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract] [Full Text] [Related]
15. Rapid KRAS, EGFR, BRAF and pik3ca mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.
van Eijk R; Licht J; Schrumpf M; Talebian Yazdi M; Ruano D; Forte GI; Nederlof PM; Veselic M; Rabe KF; Annema JT; Smit V; Morreau H; van Wezel T
PLoS One; 2011 Mar; 6(3):e17791. PubMed ID: 21408138
[TBL] [Abstract] [Full Text] [Related]
16. mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis.
Yu J; Henske EP
Lymphat Res Biol; 2010 Mar; 8(1):43-9. PubMed ID: 20235886
[TBL] [Abstract] [Full Text] [Related]
